Activism may help those with AIDS cope better with illness
CHAMPAIGN, Ill. -- The world AIDS conference last month offered a large dose of grim news about the disease and its precursor, HIV.
But a new university study suggests that there is at least one glimmer of hope.
In a recent article in the Journal of Social and Personal Relationships, researchers report that social activism in groups such as ACT UP may have a positive effect on the way people with AIDS and HIV cope with their medical and psychological problems.
The research team found that in comparison with nonactivists, activist group members used more problem-focused coping and less emotion-focused coping; had greater knowledge of HIV-treatment information sources; and had greater integration into networks of people living with HIV or AIDS.
"Many individuals living with HIV or AIDS have engaged in social activism and advocating for their health-care needs," said Dale Brashers, the lead author and a professor of speech communication at the University of Illinois at Urbana-Champaign. "They have had a major impact on the
health-care system, such as changes in how prescription drugs are tested and approved. Now it appears that their behaviors also are reflected in more active engagement with their health-care providers and more fully developed support networks of other people living with the disease. There appear to be advantages to a more active orientation toward health care."
The study, involving a survey of 174 people, mostly gay white males, is the first of its kind and "an important step toward developing theories about the impact of activist group membership on individual members," Brashers said.
Although collective action has been a significant part of the political and cultural contexts of people living with HIV or AIDS, "little is known about the individual characteristics and behavioral patterns of those who engage in social activism," he said. Other findings:
Asked to name sources of information about AIDS or HIV, activists were more likely to list nontraditional sources -- Internet sites and pharmaceutical companies -- whereas nonactivists were more likely to list traditional sources -- health-care providers and the media.
Activist group members had higher levels of education and had known about their AIDS or HIV-positive status longer than had nonactivists (72.1 months versus 53.7 months).
Activist members were more likely to receive services and volunteer at AIDS service organizations.
There is much left to do in this new area of research, including work that explores "the ways in which these variables are connected to health outcomes," Brashers said.
Brashers is completing a study that focuses on the connection between activism and improved physical and mental health. Currently testing a skills-training program, he will be looking at the data within the next few months.
Related HIV Articles from Brightsurf:
BEAT-HIV Delaney collaboratory issues recommendations measuring persistent HIV reservoirs
Spearheaded by Wistar scientists, top worldwide HIV researchers from the BEAT-HIV Martin Delaney Collaboratory to Cure HIV-1 Infection by Combination Immunotherapy (BEAT-HIV Collaboratory) compiled the first comprehensive set of recommendations on how to best measure the size of persistent HIV reservoirs during cure-directed clinical studies.
The Lancet HIV: Study suggests a second patient has been cured of HIV
A study of the second HIV patient to undergo successful stem cell transplantation from donors with a HIV-resistant gene, finds that there was no active viral infection in the patient's blood 30 months after they stopped anti-retroviral therapy, according to a case report published in The Lancet HIV journal and presented at CROI (Conference on Retroviruses and Opportunistic Infections).
Children with HIV score below HIV-negative peers in cognitive, motor function tests
Children who acquired HIV in utero or during birth or breastfeeding did not perform as well as their peers who do not have HIV on tests measuring cognitive ability, motor function and attention, according to a report published online today in Clinical Infectious Diseases.
Efforts to end the HIV epidemic must not ignore people already living with HIV
Efforts to prevent new HIV transmissions in the US must be accompanied by addressing HIV-associated comorbidities to improve the health of people already living with HIV, NIH experts assert in the third of a series of JAMA commentaries.
The Lancet HIV: Severe anti-LGBT legislations associated with lower testing and awareness of HIV in African countries
This first systematic review to investigate HIV testing, treatment and viral suppression in men who have sex with men in Africa finds that among the most recent studies (conducted after 2011) only half of men have been tested for HIV in the past 12 months.
The Lancet HIV: Tenfold increase in number of adolescents on HIV treatment in South Africa since 2010, but many still untreated
A new study of more than 700,000 one to 19-year olds being treated for HIV infection suggests a ten-fold increase in the number of adolescents aged 15 to 19 receiving HIV treatment in South Africa, according to results published in The Lancet HIV journal.
Starting HIV treatment in ERs may be key to ending HIV spread worldwide
In a follow-up study conducted in South Africa, Johns Hopkins Medicine researchers say they have evidence that hospital emergency departments (EDs) worldwide may be key strategic settings for curbing the spread of HIV infections in hard-to-reach populations if the EDs jump-start treatment and case management as well as diagnosis of the disease.
NIH HIV experts prioritize research to achieve sustained ART-free HIV remission
Achieving sustained remission of HIV without life-long antiretroviral therapy (ART) is a top HIV research priority, according to a new commentary in JAMA by experts at the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health.
The Lancet HIV: PrEP implementation is associated with a rapid decline in new HIV infections
Study from Australia is the first to evaluate a population-level roll-out of pre-exposure prophylaxis (PrEP) in men who have sex with men.
Researchers date 'hibernating' HIV strains, advancing BC's leadership in HIV cure research
Researchers have developed a novel way for dating 'hibernating' HIV strains, in an advancement for HIV cure research.
Read More: HIV News and HIV Current Events